ZA200207969B - Therapeutically useful new salts of CCK inhibitors, process for the preparation thereof and pharmaceutical preparations containing them. - Google Patents

Therapeutically useful new salts of CCK inhibitors, process for the preparation thereof and pharmaceutical preparations containing them. Download PDF

Info

Publication number
ZA200207969B
ZA200207969B ZA200207969A ZA200207969A ZA200207969B ZA 200207969 B ZA200207969 B ZA 200207969B ZA 200207969 A ZA200207969 A ZA 200207969A ZA 200207969 A ZA200207969 A ZA 200207969A ZA 200207969 B ZA200207969 B ZA 200207969B
Authority
ZA
South Africa
Prior art keywords
new
polymorphs
ethanolamine
solvates
composition
Prior art date
Application number
ZA200207969A
Other languages
English (en)
Inventor
Hermecz Istvan Horvath Agnes
Gyulane Kiss
Miklos Morvai
Benjamin Podanyi
Kalman Simon
Judit Sipos
Agota Smelkone Esek
Anna Szabo
Arpadne Vasvari
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ZA200207969B publication Critical patent/ZA200207969B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200207969A 2000-04-07 2002-10-03 Therapeutically useful new salts of CCK inhibitors, process for the preparation thereof and pharmaceutical preparations containing them. ZA200207969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0001417A HUP0001417A2 (hu) 2000-04-07 2000-04-07 Gyógyászatilag alkalmazható új sók, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények

Publications (1)

Publication Number Publication Date
ZA200207969B true ZA200207969B (en) 2004-02-10

Family

ID=89978239

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200207969A ZA200207969B (en) 2000-04-07 2002-10-03 Therapeutically useful new salts of CCK inhibitors, process for the preparation thereof and pharmaceutical preparations containing them.

Country Status (21)

Country Link
US (1) US20030176475A1 (no)
EP (1) EP1274707A1 (no)
JP (1) JP2003530396A (no)
KR (1) KR20020084296A (no)
CN (1) CN1420885A (no)
AU (1) AU2001248656A1 (no)
BG (1) BG107219A (no)
BR (1) BR0109890A (no)
CA (1) CA2405004A1 (no)
CZ (1) CZ20023671A3 (no)
EA (1) EA200201076A1 (no)
EE (1) EE200200582A (no)
HU (2) HUP0001417A2 (no)
IL (1) IL152005A0 (no)
IS (1) IS6577A (no)
MX (1) MXPA02009887A (no)
NO (1) NO20024802D0 (no)
PL (1) PL362650A1 (no)
SK (1) SK15052002A3 (no)
WO (1) WO2001077108A1 (no)
ZA (1) ZA200207969B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142390A (en) 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7164383B2 (en) 2002-09-25 2007-01-16 The Board Of Regents Of The University Of Oklahoma Navigation system using locally augmented GPS
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
EP3127427B1 (en) 2009-05-29 2020-01-08 Novartis Ag Methods of administration of thrombopoietin agonist compounds
ES2926790T3 (es) * 2016-05-04 2022-10-28 Youngene Therapeutics Co Ltd Solvato de dietilamina del inhibidor del transportador de sodio-glucosa, y método de preparación y aplicación del mismo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4970713A1 (es) * 1997-09-19 2000-11-07 Sanofi Synthelabo Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
US20030176475A1 (en) 2003-09-18
AU2001248656A1 (en) 2001-10-23
HUP0204476A2 (en) 2003-05-28
NO20024802L (no) 2002-10-04
BR0109890A (pt) 2003-06-03
MXPA02009887A (es) 2003-06-17
EP1274707A1 (en) 2003-01-15
EA200201076A1 (ru) 2003-04-24
PL362650A1 (en) 2004-11-02
BG107219A (bg) 2003-05-30
SK15052002A3 (sk) 2003-05-02
HU0001417D0 (en) 2000-06-28
JP2003530396A (ja) 2003-10-14
CZ20023671A3 (cs) 2003-05-14
WO2001077108A1 (en) 2001-10-18
EE200200582A (et) 2004-04-15
IL152005A0 (en) 2003-04-10
KR20020084296A (ko) 2002-11-04
HUP0001417A2 (hu) 2002-12-28
IS6577A (is) 2002-10-02
NO20024802D0 (no) 2002-10-04
CN1420885A (zh) 2003-05-28
CA2405004A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2018287777B2 (en) SSAO inhibitor
CA2829322C (en) Substituted thioimidazolidinone androgen receptor antagonists and uses thereof
DE69427289T2 (de) Naphtalinderivate
TWI280127B (en) Remedies for neurodegenerative diseases
JP5897566B2 (ja) 環式n,n’−ジアリールチオ尿素及びn,n’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用
EP3567035A1 (en) N-substituted 2,5-dioxo-azoline compounds for use in the treatment of cancer
CZ20032696A3 (cs) Thiohydantoiny a jejich použití při léčení cukrovky
JP2002047288A (ja) 置換チアゾリジンジオン誘導体
JPS62161728A (ja) 抗菌剤
CZ376798A3 (cs) Nepeptidové látky podobné G-CSF
EP2970128B1 (en) Base addition salts of nitroxoline and uses thereof
FR2537140A1 (fr) Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
ZA200207969B (en) Therapeutically useful new salts of CCK inhibitors, process for the preparation thereof and pharmaceutical preparations containing them.
EP2870141B1 (en) Methanethione compounds having antiviral activity
KR20100063105A (ko) Tsh 수용체를 길항하는 테트라하이드로퀴놀린 화합물
CN107827837B (zh) 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用
EP1944024A1 (en) O-substituted aniline derivative and antioxidant drug
JP4965428B2 (ja) セミカルバジド誘導体を含むフリーラジカル消去剤
JPH10507446A (ja) ビス−2−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
CN105814018B (zh) 新型脲类化合物、制备方法及其用途
KR100832750B1 (ko) N-페닐아마이드 유도체를 함유하는 허혈성 질환의 예방또는 치료용 조성물
JP2837318B2 (ja) アンジオテンシンii拮抗性ピリジン誘導体
US6117867A (en) Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
KR100307660B1 (ko) 도파민재소비저해제
NZ201795A (en) Anilino-1,2,3-triazole derivatives and pharmaceutical compositions